文献速递炎症性肠病消化内镜

溃疡性结肠炎患者储袋手术的结局由术前因素决定

The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors.
PubMed 文献 · Aliment Pharmacol Ther · 2017-06-30

该回顾性非匹配病例队列研究在三级炎症性肠病转诊中心纳入253例成人溃疡性结肠炎储袋手术患者,随访13.1±7.3年,仅28.1%维持持续正常储袋。因非难治性并发症(异型增生/肿瘤)手术者结局更优,中位持续正常储袋生存期20.3年 vs 难治性组9.4年(HR=2.37,95%CI 1.25-3.52,P=.004)。

要点

  • 仅28.1%患者维持持续正常储袋,多数将发生储袋炎。
  • 因非难治性并发症手术者持续正常储袋生存期更长(20.3 vs 9.4年,HR=2.37)。
  • 术前因素(诊断年龄、病程、手术指征)与储袋结局相关。

核心结论

  • 多数接受储袋手术的溃疡性结肠炎患者将发生储袋炎。
  • 因非难治性指征手术的患者结局更有利。
  • 这些结果可能有助于术前和术后决策。
  • 研究提示决定溃疡性结肠炎严重程度的机制可能与引起储袋炎的机制相似。

研究设计与样本

  • 回顾性非匹配病例队列研究,在三级炎症性肠病转诊中心开展。
  • 纳入253例成人溃疡性结肠炎储袋手术患者,随访13.1±7.3年。
  • 按随访期间最差表型分类:正常储袋、慢性储袋炎(慢性储袋炎或储袋克罗恩样病[CLDP])、发作性复发性急性储袋炎(RAP)。
  • 采用统计模型检测储袋炎(慢性形式)的危险因素。

主要发现

  • 仅71例患者(28.1%)维持持续正常储袋的良好结局。
  • 持续正常储袋患者相比储袋炎患者:诊断溃疡性结肠炎年龄更大(27.8±12.5 vs 23.0±11.4岁)。
  • 持续正常储袋患者相比储袋炎患者:至手术的溃疡性结肠炎病程更长(13.4±9.5 vs 8.2±7.9年)。
  • 持续正常储袋患者相比储袋炎患者:因非难治性(异型增生/肿瘤)并发症转诊手术的比例更高(42.3% vs 16.2%)。
  • 持续正常储袋的中位生存期为10.8年(95%CI 8.9-12.7年),非难治性组更长(20.3 vs 难治性组9.4年,HR=2.37,95%CI 1.25-3.52,P=.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pouch surgery, a common intervention for ulcerative colitis (UC) complications, is often associated with the development of pouchitis. AIM: To identify predictors of pouch outcome in a cohort of patients with UC. METHODS: We conducted a retrospective unmatched case-cohort study in a tertiary IBD referral centre. Adult patients with UC were classified into the worst phenotype throughout follow-up: normal pouch, a form of chronic pouchitis (either chronic pouchitis or Crohn's like disease of pouch [CLDP]), or episodic recurrent acute pouchitis (RAP). Risk factors for pouchitis (chronic forms) were detected using statistical models. RESULTS: Two hundred and fifty-three pouch patients were followed up for 13.1±7.3 years. Only 71 patients (28.1%) maintained a favourable outcome of a sustained normal pouch. These patients were older at UC diagnosis (27.8±12.5 vs 23.0±11.4 years), had longer UC duration until surgery (13.4±9.5 vs 8.2±7.9 years), and had higher rates of referral to surgery due to nonrefractory (dysplasia/neoplasia) complications (42.3% vs 16.2%) compared with pouchitis patients. Median survival for sustained normal pouch was 10.8 years (95% CI 8.9-12.7 years), and it was longer in the nonrefractory group (20.3 vs 9.4 years for the refractory group, HR=2.37, 95% CI 1.25-3.52, P=.004). CONCLUSIONS: Most patients with UC undergoing pouch surgery will develop pouchitis. Patients operated for nonrefractory indications have a more favourable outcome. These results may contribute to pre- and post-surgical decision-making. The findings imply that the processes determining UC severity may be similar to that causing pouchitis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Yanai H, Ben-Shachar S, Mlynarsky L, et al. The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors. Aliment Pharmacol Ther. 2017. PMID: 28664992. doi:10.1111/apt.14205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。